Cover Image

Candidate drug repurposing for malaria: perspectives for optimising clinical trials

Saved in:

Bibliographic Details
Main Author:	J. Luis Espinoza (Author)
Format:	Book
Published:	Elsevier, 2025-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Repurposable Drugs for Immunotherapy and Strategies to Find Candidate Drugs
by: Norihiro Sakai, et al.
Published: (2023)

Towards Drug Repurposing in Cancer Cachexia: Potential Targets and Candidates
by: Joana M. O. Santos, et al.
Published: (2021)

Drug repurposing candidates to treat core symptoms in autism spectrum disorder
by: Elise Koch, et al.
Published: (2022)

A Database of Drug Repurposing Clinical Trials in Oncology
by: Pan Pantziarka, et al.
Published: (2021)

Repurposing Old Drugs into New Epigenetic Inhibitors: Promising Candidates for Cancer Treatment?
by: Filipa Moreira-Silva, et al.
Published: (2020)

Screening of Benzimidazole-Based Anthelmintics and Their Enantiomers as Repurposed Drug Candidates in Cancer Therapy
by: Rosalba Florio, et al.
Published: (2021)

Repurposing Anti-Malaria Phytomedicine Artemisinin as a COVID-19 Drug
by: Fatih M. Uckun, et al.
Published: (2021)

Characterization of T-cell immune responses in clinical trials of the candidate RTS,S malaria vaccine
by: Philippe Moris, et al.
Published: (2018)

Discovery of repurposing drug candidates for the treatment of diseases caused by pathogenic free-living amoebae.
by: Christopher A Rice, et al.
Published: (2020)

AI drug discovery screening for COVID-19 reveals zafirlukast as a repurposing candidate
by: Marcin Delijewski, et al.
Published: (2021)

Drug repurposing for rheumatoid arthritis: Identification of new drug candidates via bioinformatics and text mining analysis
by: Ulku Unal, et al.
Published: (2022)

Active repurposing of drug candidates for melanoma based on GWAS, PheWAS and a wide range of omics data
by: Ali Khosravi, et al.
Published: (2019)

PBPK‐led assessment of antimalarial drugs as candidates for Covid‐19: Simulating concentrations at the site of action to inform repurposing strategies
by: Nada Abla, et al.
Published: (2024)

New malaria drug candidate could cure in a single dose
by: Robert Walgate
Published: (2002)

Repurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasis.
by: Christina A Bulman, et al.
Published: (2015)

Identification of 37 Heterogeneous Drug Candidates for Treatment of COVID-19 via a Rational Transcriptomics-Based Drug Repurposing Approach
by: Andrea Gelemanović, et al.
Published: (2021)

A target repurposing approach identifies N-myristoyltransferase as a new candidate drug target in filarial nematodes.
by: Brendan D Galvin, et al.
Published: (2014)

Open-source approaches for the repurposing of existing or failed candidate drugs: learning from and applying the lessons across diseases
by: Allarakhia M
Published: (2013)

A Review of Repurposed Cancer Drugs in Clinical Trials for Potential Treatment of COVID-19
by: Bárbara Costa, et al.
Published: (2021)

Repurposing Disulfiram (Tetraethylthiuram Disulfide) as a Potential Drug Candidate against <i>Borrelia burgdorferi</i> In Vitro and In Vivo
by: Hari-Hara S. K. Potula, et al.
Published: (2020)

Identification of biomarkers and drug repurposing candidates based on an immune-, inflammation- and membranous glomerulonephritis-associated triplets network for membranous glomerulonephritis
by: Chengwei Zhang, et al.
Published: (2020)

Antifungal Drug Repurposing
by: Jong H. Kim, et al.
Published: (2020)

The Challenge of Interpreting Alanine Aminotransferase Elevations in Clinical Trials of New Drug Candidates
by: Rachel J. Church, et al.
Published: (2021)

Optimisation of Approaches to Adverse Event Analysis in Bioequivalence Clinical Trials
by: A. B. Verveda, et al.
Published: (2024)

DRUG REPURPOSING-Overcoming the translational hurdles to clinical use
by: Jennifer H. Martin, et al.
Published: (2019)

Drug Repurposing Advances, Scopes and Opportunities in Drug Discovery
Published: (2023)

Drug Repurposing for Targeting Myeloid-Derived Suppressor-Cell-Generated Immunosuppression in Ovarian Cancer: A Literature Review of Potential Candidates
by: Yani Berckmans, et al.
Published: (2023)

Drug Repurposing Molecular Aspects and Therapeutic Applications
Published: (2022)

Drug Repurposing for Schistosomiasis: Combinations of Drugs or Biomolecules
by: Maria João Gouveia, et al.
Published: (2018)

Drug Repurposing Hypothesis, Molecular Aspects and Therapeutic Applications
Published: (2020)

Repurposing - second life for drugs
by: Porkodi Ayyar, et al.
Published: (2022)

Candidates for Repurposing as Anti-Virulence Agents Based on the Structural Profile Analysis of Microbial Collagenase Inhibitors
by: Georgiana Nitulescu, et al.
Published: (2021)

Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion
by: Elizabeth J. Wilk, et al.
Published: (2023)

Withaferin A: A potential anticancer candidate drug and its challenges for the clinical trial
by: Sangilimuthu Alagar Yadav, et al.
Published: (2024)

Drug repurposing strategies of relevance for Parkinson's disease
by: Edward J. R. Fletcher, et al.
Published: (2021)

Drug repurposing for the treatment of COVID-19
by: Yuri Kato, et al.
Published: (2022)

Informatics on Drug Repurposing for Breast Cancer
by: Zhou H, et al.
Published: (2023)

Anthelmintics for drug repurposing: Opportunities and challenges
by: Seyed Ebrahim Alavi, et al.
Published: (2021)

Drug-Repurposing Strategy for Dimethyl Fumarate
by: Salvatore Giunta, et al.
Published: (2023)

Drug repurposing clinical trials in the search for life-saving COVID-19 therapies; research targets and methodological and ethical issues
by: Francisco José Roma Paumgartten, et al.
Published: (2020)